CRISPR's Next Advance Is Bigger Than You Think | Jennifer Doudna | TED

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

FDA considers 1st CRISPR gene editing treatment that may cure sickle cell disease

Peter Marks on FDA Regulation of CRISPR, Gene Therapies

CRISPR Explained

CRISPR-Cas9 Explained: The First FDA-Approved Gene Therapy and Its Revolutionary Impact

Understanding the FDA Approval Process for Gene Therapies: Step-by-Step Explanation

A 7-Year-Old's Blindness was Reversed by the 1st FDA-Approved Gene Therapy for Retinal Degeneration

FDA Approves CRISPR

The regulation of emerging technologies: responses to the rise of CRISPR gene editing

Keynote Presentation: A Regulatory Perspective on Molecular Diagnostic Devices

5 Ways CRISPR Is About to Change Everything

FDA Provides Designation to $CRSP for CTX110. (Ep. 201)

FDA Regulation of Cell and Gene Therapies: Facilitating Advanced Manufacturing

CRISPR Tx Submits for FDA Approval

Rethinking Information Asymmetries: Regulating Medical Therapies using Genomic Alteration at the FDA

FDA Approves First CRISPR Treatment in U.S.

FDA Guidance on Genome Editing

Game Change – CRISPR's Brave New World

CRISPR Tx & FDA